Consonance Capital Partners Announces Charlie Kolisek as Vice President

Experienced healthcare investment professional joins firm to support continued growth

NEW YORK--(BUSINESS WIRE)--Consonance Capital Partners ("CCP"), a private equity firm focused exclusively on investing in the U.S. healthcare industry, today announced that Charlie Kolisek has joined the firm as a Vice President.

Mr. Kolisek brings significant healthcare private equity experience to CCP. He joins the firm from GTCR, where he was an investment professional in the firm's Healthcare group. Prior to GTCR, he was an investment professional at Carlyle, and he began his career as an investment banking analyst at J.P. Morgan.

"We are pleased to welcome Charlie to Consonance Capital Partners," said Javier Starkand, Partner at CCP. “His sector expertise, healthcare investing experience and extensive network of relationships will be valuable additions to our firm as we continue to partner with founders and management teams to build differentiated and durable healthcare businesses with long-term growth potential."

Mr. Kolisek holds an MBA from the Wharton School of the University of Pennsylvania and a BA in Mathematics and Economics from Wabash College.

About Consonance Capital Partners

Consonance Capital Partners invests in private companies in the lower and middle markets of the U.S. healthcare industry, with an emphasis on businesses driving efficiency, cost containment, and high-quality care to patients. Consonance Capital Partners participates in growth equity, leveraged buyout, carve-out, recapitalization, and special situation transactions. For more information, visit www.consonancecapitalpartners.com.